Adage Capital Management

Total investments

109

Average round size

96M

Portfolio companies

85

Rounds per year

4.74

Lead investments

6

Follow on index

0.19

Exits

51

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsGeneticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

The venture was found in North America in United States. The main office of represented VC is situated in the Boston.

The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Adage Capital Management, startups are often financed by Morgenthaler Ventures, QuestMark Partners, Lightspeed Venture Partners. The meaningful sponsors for the fund in investment in the same round are Rock Springs Capital, T. Rowe Price, OrbiMed. In the next rounds fund is usually obtained by Redmile Group, Morgenthaler Ventures, SightLine Partners.

The real fund results show that this VC is 4 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this Adage Capital Management works on 33 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Adage Capital Management is more than 1 billion dollars. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2014.

Among the most popular portfolio startups of the fund, we may highlight AveXis, Tanium, MuleSoft. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.

The fund was created by Phillip Gross, Robert George Atchinson. The overall number of key employees were 4.

Show more

Investments analytics

Analytics

Total investments
109
Lead investments
6
Exits
51
Rounds per year
4.74
Follow on index
0.19
Investments by industry
  • Biotechnology (81)
  • Health Care (53)
  • Therapeutics (47)
  • Medical (35)
  • Pharmaceutical (22)
  • Show 54 more
Investments by region
  • United States (89)
  • United Kingdom (4)
  • Switzerland (1)
  • Canada (3)
  • China (1)
  • Show 3 more
Peak activity year
2021
Number of Unicorns
4
Number of Decacorns
5
Number of Minotaurs
8

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Avg. valuation at time of investment
419M
Group Appearance index
1.00
Avg. company exit year
9
Avg. multiplicator
1.27
Strategy success index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Menlo Micro 09 Mar 2022 Hardware, Semiconductor, Consumer Electronics, Electronics, Power Grid Late Stage Venture 150M United States, California, Irvine
Welldoc 17 Dec 2015 Fitness, Health Care, Wellness, Real Time, Medical, Therapeutics, Diabetes Early Stage Venture 22M United States, Maryland, Columbia

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.